These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21858154)

  • 1. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
    Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
    PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 1,25 dihydroxyvitamin D3 treatment on the mRNA levels of β catenin target genes in mice with colonic inactivation of both APC alleles.
    DeWitt M; Johnson RL; Snyder P; Fleet JC
    J Steroid Biochem Mol Biol; 2015 Apr; 148():103-10. PubMed ID: 25597951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the vitamin D receptor in APC(min/+) mice reveals a critical role for the vitamin D receptor in intestinal tumor growth.
    Zheng W; Wong KE; Zhang Z; Dougherty U; Mustafi R; Kong J; Deb DK; Zheng H; Bissonnette M; Li YC
    Int J Cancer; 2012 Jan; 130(1):10-9. PubMed ID: 21328347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
    Bong YS; Assefnia S; Tuohy T; Neklason DW; Burt RW; Ahn J; Bueno De Mesquita PJ; Byers SW
    Oncotarget; 2016 Dec; 7(49):80508-80520. PubMed ID: 27768599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells.
    Larriba MJ; Valle N; Pálmer HG; Ordóñez-Morán P; Alvarez-Díaz S; Becker KF; Gamallo C; de Herreros AG; González-Sancho JM; Muñoz A
    Endocr Relat Cancer; 2007 Mar; 14(1):141-51. PubMed ID: 17395983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
    Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
    Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
    Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
    Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
    Egan JB; Thompson PA; Vitanov MV; Bartik L; Jacobs ET; Haussler MR; Gerner EW; Jurutka PW
    Mol Carcinog; 2010 Apr; 49(4):337-52. PubMed ID: 20043299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1,25-dihydroxyvitamin D3 on the Wnt pathway in non-malignant colonic cells.
    Gröschel C; Aggarwal A; Tennakoon S; Höbaus J; Prinz-Wohlgenannt M; Marian B; Heffeter P; Berger W; Kállay E
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):224-30. PubMed ID: 25777538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development.
    Shelton DN; Sandoval IT; Eisinger A; Chidester S; Ratnayake A; Ireland CM; Jones DA
    Cancer Res; 2006 Aug; 66(15):7571-7. PubMed ID: 16885356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells.
    Ordóñez-Morán P; Larriba MJ; Pálmer HG; Valero RA; Barbáchano A; Duñach M; de Herreros AG; Villalobos C; Berciano MT; Lafarga M; Muñoz A
    J Cell Biol; 2008 Nov; 183(4):697-710. PubMed ID: 19015318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
    Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
    PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
    Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
    J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A antagonist inhibits β-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in Apc(Min/+) mice.
    Brudvik KW; Paulsen JE; Aandahl EM; Roald B; Taskén K
    Mol Cancer; 2011 Dec; 10():149. PubMed ID: 22168384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas.
    Giardina C; Nakanishi M; Khan A; Kuratnik A; Xu W; Brenner B; Rosenberg DW
    Cancer Prev Res (Phila); 2015 May; 8(5):387-99. PubMed ID: 25873367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines.
    Beildeck ME; Islam M; Shah S; Welsh J; Byers SW
    PLoS One; 2009 Nov; 4(11):e7872. PubMed ID: 19924301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling.
    Guo H; Nagy T; Pierce M
    J Biol Chem; 2014 Nov; 289(45):31534-49. PubMed ID: 25274627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
    Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
    Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.